Big Pharma Embraces Biologics

News   Nov 30, 2012

 
Big Pharma Embraces Biologics
 
 
 

RELATED ARTICLES

Biosimilar Drugs Could Help Cut US Healthcare Spending

News

Introducing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade.

READ MORE

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News

Partnership to evaluate cocrystal formulations using translational pharmaceutics.

READ MORE


 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE